2014
DOI: 10.1007/s00894-014-2512-1
|View full text |Cite
|
Sign up to set email alerts
|

Monte Carlo simulation of mixed nonionic Brij surfactants in water

Abstract: Nonionic surfactants such as the Brij® series are important in the preparation of transdermal drug nanodelivery products using nanoemulsions because of their low toxicity and low irritancy. Here, Monte Carlo (MC) simulation was used to examine the physical behavior of the model deterministic system by using sampling procedures. Metropolis MC simulations were run on three mixtures of two different nonionic surfactants, Brij92 and Brij96, with different compositions in aqueous solution. The system was simulated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…An effective screening methodology for the appropriate choice of oils, surfactants, and cosurfactants assists in superior formulation for NEs with attractive properties. 14 Therefore, many important concerns should be considered including drug solubility in oil phase, where generally lipophilic drugs are more soluble in O/W NEs, while hydrophilic drugs are more soluble in W/O NEs; volume of formulation where low-molar-volume oils is preferable, 15 and surfactants' toxicity where nonionic surfactants are preferable for oral, parenteral, and transdermal preparations as they are comparatively less toxic than their ionic counterparts 16 ; moreover, surfactant's nature, where the hydrophilic-lipophilic balance (HLB) of the surfactant defines the emulsion type. For instance, a surfactant with an HLB value greater than 10 is required for O/W NE, offering minimum globule size.…”
Section: S Elec Tion Of Nanoemul S Ion Comp Onentsmentioning
confidence: 99%
“…An effective screening methodology for the appropriate choice of oils, surfactants, and cosurfactants assists in superior formulation for NEs with attractive properties. 14 Therefore, many important concerns should be considered including drug solubility in oil phase, where generally lipophilic drugs are more soluble in O/W NEs, while hydrophilic drugs are more soluble in W/O NEs; volume of formulation where low-molar-volume oils is preferable, 15 and surfactants' toxicity where nonionic surfactants are preferable for oral, parenteral, and transdermal preparations as they are comparatively less toxic than their ionic counterparts 16 ; moreover, surfactant's nature, where the hydrophilic-lipophilic balance (HLB) of the surfactant defines the emulsion type. For instance, a surfactant with an HLB value greater than 10 is required for O/W NE, offering minimum globule size.…”
Section: S Elec Tion Of Nanoemul S Ion Comp Onentsmentioning
confidence: 99%